Drug Profile
Buserelin - Pharm-Sintez
Alternative Names: Buserelin; Buserelin depo - Pharm-Sintez; Buserelin nasal spray - Pharm-Sintez; Buserelin-depo; Gonadotropin releasing harmone analogue - Pharm-SintezLatest Information Update: 22 Sep 2021
Price :
$50
*
At a glance
- Originator Pharm-Sintez
- Class Antineoplastics; Hormones; Infertility therapies; Oligopeptides
- Mechanism of Action LHRH receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Breast cancer; Endometrial hyperplasia; Endometriosis; Infertility; Leiomyoma; Prostate cancer